% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • pg135788 pg135788 Jul 12, 2009 4:05 PM Flag

    Something negative is up with RXII

    The stock price has been going down every week. The probably will announce a pipe deal soon if Im correct. This is what sucks about a so called public company. Its public only for the shareholders but the insiders know whats going to take place like a pipe deal. I am digusted with this stock price. In 2007 Wolf reported they were going to have a deal signed. Now when I spoke to there investor relations girl,she says because of the drug firms merging there deals were cancelled. More BS. I wonder if Kriegsmen knew of a possible pipe ...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I believe Kriegsman accounted for close to 10% of all stock sales over the past 3 months. Now that he has sold all of his shares, I believe ...I'm waiting for the final 8-K, this stock will stop going down and may actually go up somewhat from here.

      They do need more money, so it still may go lower before it goes higher, but I would think with the value of the patents that they own, it could be very close to the bottom.

      I'm still hesitant to buy, but I also don't believe that I would sell here at this price.

    • Last August RXI announced that JP Turner & Co. were their investment banker and started paying them $19,000 PER MONTH for investment banking advice and services.

      I'm not a big fan of JP Turner & Co.....

      • 1 Reply to sbilko60
      • RXi Pharmaceuticals Corp. Announces Investment
        Banking Agreement with J.P. Turner & Company, L.L.C


        On August 7, 2008, RXi Pharmaceuticals Corporation entered into an Investment Banking Agreement with J.P. Turner & Company, L.L.C., pursuant to which Turner agreed to provide business advisory services to the Company for a period of up to twelve months in exchange for (i) a monthly advisory fee equal to $19,000 per month, and (ii) the issuance by the Company of warrants to purchase 190,000 shares of the Company's common stock at an exercise price per share equal to the average closing price of the Company's common stock for the ten trading days ending three days prior to August 7, 2008, or $7.07 per share. The Warrants will vest as to 94,000 shares upon issuance, and then at a rate of 32,000 shares per month starting on the 90 day anniversary of issuance, and are exercisable for a period of five years. The Company has also agreed to give Turner unlimited 'piggy back' registration rights with respect to the shares of the Company's common stock underlying the Warrants in any registration statement filed by the Company in connection with an underwritten offering of the Company's common stock.

0.3503+0.0218(+6.64%)Sep 30 4:00 PMEDT